John Patience - Aug 17, 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director, Chairman, 10%+ Owner
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Stock symbol
BDSX
Transactions as of
Aug 17, 2021
Transactions value $
$11,416
Form type
4
Date filed
8/19/2021, 03:00 PM
Previous filing
Jul 1, 2021
Next filing
Aug 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Purchase $11.4K +1.6K +0.08% $7.12 1.91M Aug 17, 2021 By Patience Enterprises LP F1, F3, F4
holding BDSX Common Stock 58.6K Aug 17, 2021 Direct
holding BDSX Common Stock 2.81M Aug 17, 2021 By John Patience Living Trust dated 7/23/1993 F2, F5
holding BDSX Common Stock 30K Aug 17, 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.94 to $7.25, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F4 In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 98 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.
F5 In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 78 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.